AAAAAA
Results:
1-11
|
Results: 11
Authors:
Piccart, MJ
Di Leo, A
Beauduin, M
Vindevoghel, A
Michel, J
Focan, C
Tagnon, A
Ries, F
Gobert, P
Finet, C
Closon-Dejardin, MT
Dufrane, JP
Kerger, J
Liebens, F
Beauvois, S
Bartholomeus, S
Dolci, S
Lobelle, JP
Paesmans, M
Nogaret, JM
Citation: Mj. Piccart et al., Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer, J CL ONCOL, 19(12), 2001, pp. 3103-3110
Authors:
Vandeweyer, E
Hertens, D
Nogaret, JM
Deraemaecker, R
Citation: E. Vandeweyer et al., Immediate breast reconstruction with saline-filled implants: No interference with the oncologic outcome?, PLAS R SURG, 107(6), 2001, pp. 1409-1412
Authors:
Dequanter, D
Hertens, D
Veys, I
Nogaret, JM
Larsimont, D
Bourgeois, P
Citation: D. Dequanter et al., Sentinel lymph node involvement in T0T1 breast tumors., ANN CHIR, 126(7), 2001, pp. 654-658
Authors:
Gancberg, D
Lespagnard, L
Rouas, G
Paesmans, M
Piccart, M
Di Leo, A
Nogaret, JM
Hertens, D
Verhest, A
Larsimont, D
Citation: D. Gancberg et al., Sensitivity of HER-2/neu antibodies in archival tissue samples of invasivebreast carcinomas - Correlation with oncogene amplification in 160 cases, AM J CLIN P, 113(5), 2000, pp. 675-682
Authors:
Vosse, M
Renard, F
Coibion, M
Nogaret, JM
Hertens, D
Citation: M. Vosse et al., Monitoring for endometrial disorders in 406 breast cancer women treated bytamoxifen: a low aggressive strategy, EUR J CANC, 36, 2000, pp. S39-S40
Authors:
Di Leo, A
Crown, J
Nogaret, JM
Duffy, K
Bartholomeus, S
Dolci, S
Rowan, S
O'Higgins, N
Paesmans, M
Larsimont, D
Riva, A
Piccart, MJ
Citation: A. Di Leo et al., A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer, ANN ONCOL, 11(2), 2000, pp. 169-175
Authors:
Vandeweyer, E
Nogaret, JM
Hertens, D
Deraemaecker, R
Citation: E. Vandeweyer et al., Palliative chest wall reconstruction, J PAIN SYMP, 20(6), 2000, pp. 395-396
Authors:
Darro, F
Schwarz, G
Petein, M
Schwarz, S
Chaboteaux, C
Nogaret, JM
Decaestecker, C
Salmon, I
Kiss, R
Citation: F. Darro et al., Characterization of steroid hormone sensitivity in human breast cancers maintained ex vivo under organotypical culture conditions, J CANC RES, 126(5), 2000, pp. 257-262
Authors:
Bourgeois, P
Nogaret, JM
Veys, I
Hertens, D
Coibion, M
Frohling, J
Citation: P. Bourgeois et al., Sentinel node biopsy, EUR J NUCL, 25(11), 1998, pp. 1588-1589
Authors:
Darro, F
Cahen, P
Vianna, A
Decaestecker, C
Nogaret, JM
Leblond, B
Chaboteaux, C
Ramos, C
Petein, M
Budel, V
Schoofs, A
Pourrias, B
Kiss, R
Citation: F. Darro et al., Growth inhibition of human in vitro and mouse in vitro and in vivo mammarytumor models by retinoids in comparison with tamoxifen and the RU-486 anti-progestagen, BREAST CANC, 51(1), 1998, pp. 39-55
Authors:
Heymans, O
Lemaitre, J
Choghari, C
Larsimont, D
Ohana, M
Drijski, J
Nogaret, JM
Citation: O. Heymans et al., Leiomyosarcoma of the mesocolon, ACT CHIR B, 98(6), 1998, pp. 261-263
Risultati:
1-11
|